- Home
- NJR vs ALKS Comparison
NJR vs ALKS Comparison
Compare NJR & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NJR
- ALKS
- Stock Information
- Founded
- NJR 1922
- ALKS 1987
- Country
- NJR United States
- ALKS Ireland
- Employees
- NJR N/A
- ALKS N/A
- Industry
- NJR Oil/Gas Transmission
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- NJR Utilities
- ALKS Health Care
- Exchange
- NJR Nasdaq
- ALKS Nasdaq
- Market Cap
- NJR 4.8B
- ALKS 4.8B
- IPO Year
- NJR N/A
- ALKS 1991
- Fundamental
- Price
- NJR $45.82
- ALKS $31.29
- Analyst Decision
- NJR Hold
- ALKS Buy
- Analyst Count
- NJR 5
- ALKS 13
- Target Price
- NJR $51.80
- ALKS $38.85
- AVG Volume (30 Days)
- NJR 624.4K
- ALKS 1.6M
- Earning Date
- NJR 05-05-2025
- ALKS 07-23-2025
- Dividend Yield
- NJR 3.93%
- ALKS N/A
- EPS Growth
- NJR 63.33
- ALKS N/A
- EPS
- NJR 4.14
- ALKS 2.09
- Revenue
- NJR $2,072,804,000.00
- ALKS $1,513,770,000.00
- Revenue This Year
- NJR $4.48
- ALKS N/A
- Revenue Next Year
- NJR $3.46
- ALKS $4.11
- P/E Ratio
- NJR $11.06
- ALKS $14.95
- Revenue Growth
- NJR 20.48
- ALKS N/A
- 52 Week Low
- NJR $41.68
- ALKS $22.90
- 52 Week High
- NJR $51.95
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- NJR 40.70
- ALKS 57.40
- Support Level
- NJR $45.16
- ALKS $29.70
- Resistance Level
- NJR $46.31
- ALKS $31.76
- Average True Range (ATR)
- NJR 0.70
- ALKS 0.75
- MACD
- NJR -0.03
- ALKS 0.01
- Stochastic Oscillator
- NJR 35.55
- ALKS 81.64
About NJR NewJersey Resources Corporation
New Jersey Resources is an energy services holding company with regulated and nonregulated operations. Its regulated utility, New Jersey Natural Gas, delivers natural gas to nearly 600,000 customers in the state. NJR's nonregulated businesses include solar investments primarily in New Jersey and investments in several large midstream natural gas projects.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.